The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I dose-escalation results of 177Lu-NYM032 in patients with progressive metastatic castration-resistant prostate cancer (mCRPC).
 
Yanjuan Wang
No Relationships to Disclose
 
Lu Hou
No Relationships to Disclose
 
Qiaoling Xu
No Relationships to Disclose
 
Xiuqing Xue
No Relationships to Disclose
 
Jie Pan
No Relationships to Disclose
 
Hong Qi
No Relationships to Disclose
 
Peng Fang
No Relationships to Disclose
 
P. Mozley
No Relationships to Disclose
 
Alton Sartor
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Abdera Thereapeutics; Actithera; Advancell; Advancell; ARTbio; Asta; Azurna; BioNTech SE; Cardinal Health; Clarity Pharmaceuticals; Convergent Therapeutics; Curadh; Curadh; Lilly; NVision; Ratiopharm; Telix Pharmaceuticals; United Health Group
Honoraria - Actinium Pharmaceuticals; Advancell; AstraZeneca; Clarity Pharmaceuticals; Convergent Therapeutics; Intellisphere; Lantheus Medical Imaging; Pfizer; Point Therapeutics; Ratiopharm; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Abdera Thereapeutics; Actinium Pharmaceuticals; Actithera; Advancell; Alpha9; Amgen; ARTbio; Astellas Pharma; AstraZeneca; Bayer; Clarity Pharmaceuticals; Convergent Therapeutics; Curdah; Curium Pharma; Full Life; Fusion Pharmaceuticals; Isotopen Technologien; Janssen; Johnson & Johnson/Janssen; Lantheus Medical Imaging; Merck; Modex; Norroy; NorthStar; Novartis; Nucleus Radiopharma; NVision; Pfizer; Point Biopharma; Precede Bio; Progenics; Ratiopharm; Sanofi; Swiss Rockets; Syneos Health; Telix Pharmaceuticals; Telix Pharmaceuticals; Wren Laboratories; X-Cancer Software
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Janssen; Lantheus Medical Imaging (Inst); Novartis (Inst)
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - Bayer; Lantheus Medical Imaging; Sanofi
 
Chunjing Yu
No Relationships to Disclose